0.4399
price up icon7.90%   0.0322
after-market After Hours: .44 0.000100 +0.02%
loading
Immunoprecise Antibodies Ltd stock is traded at $0.4399, with a volume of 441.18K. It is up +7.90% in the last 24 hours and up +2.30% over the past month. ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.
See More
Previous Close:
$0.4077
Open:
$0.419
24h Volume:
441.18K
Relative Volume:
0.06
Market Cap:
$20.13M
Revenue:
$16.77M
Net Income/Loss:
$-11.87M
P/E Ratio:
-0.9277
EPS:
-0.4742
Net Cash Flow:
$-5.90M
1W Performance:
+21.08%
1M Performance:
+2.30%
6M Performance:
-34.83%
1Y Performance:
-69.66%
1-Day Range:
Value
$0.405
$0.44
1-Week Range:
Value
$0.3602
$0.44
52-Week Range:
Value
$0.30
$1.64

Immunoprecise Antibodies Ltd Stock (IPA) Company Profile

Name
Name
Immunoprecise Antibodies Ltd
Name
Phone
-
Name
Address
-
Name
Employee
101
Name
Twitter
Name
Next Earnings Date
2024-09-16
Name
Latest SEC Filings
Name
IPA's Discussions on Twitter

Compare IPA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
IPA
Immunoprecise Antibodies Ltd
0.4399 20.13M 16.77M -11.87M -5.90M -0.4742
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
512.52 131.61B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
672.36 73.51B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
619.97 37.67B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
253.44 32.81B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
266.26 28.62B 3.81B -644.79M -669.77M -6.24

Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-02-22 Initiated H.C. Wainwright Buy
Oct-25-21 Initiated The Benchmark Company Buy

Immunoprecise Antibodies Ltd Stock (IPA) Latest News

pulisher
Mar 17, 2025

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 17, 2025
pulisher
Mar 17, 2025

ImmunoPrecise Antibodies’ (IPA) Buy Rating Reiterated at HC Wainwright - Defense World

Mar 17, 2025
pulisher
Mar 13, 2025

ImmunoPrecise partners for cancer drug advancement By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

What's Going On With ImmunoPrecise Stock Thursday? - Benzinga

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics. - 01Net

Mar 13, 2025
pulisher
Mar 13, 2025

Sector Update: Health Care -March 13, 2025 at 08:52 am EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunoPrecise Antibodies Signs Partnership Deal to Develop Cancer Treatments -March 13, 2025 at 07:55 am EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunoPrecise Antibodies Partners for $10M Cancer Therapeutics Development - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Positive Signs As Multiple Insiders Buy ImmunoPrecise Antibodies Stock - Yahoo Finance

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunoPrecise partners for cancer drug advancement - Investing.com

Mar 13, 2025
pulisher
Mar 12, 2025

IPA to Reschedule Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 28, 2025 - 01Net

Mar 12, 2025
pulisher
Mar 11, 2025

ImmunoPrecise Q3 Earnings Postponed: Auditors Request Extra Time for Goodwill Review - StockTitan

Mar 11, 2025
pulisher
Mar 11, 2025

ImmunoPrecise Antibodies Reschedules Q3 Financial Results Release - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Immunoprecise Antibodies Ltd expected to post a loss of 8 cents a shareEarnings Preview - TradingView

Mar 11, 2025
pulisher
Mar 06, 2025

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Short Interest Update - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

ImmunoPrecise Antibodies (IPA) to Release Earnings on Thursday - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

ImmunoPrecise’s BioStrand(R) Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery - ACCESS Newswire

Mar 05, 2025
pulisher
Mar 05, 2025

ImmunoPrecise Antibodies to Announce Q3 Fiscal 2025 Results - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

AI Antibody Pioneer ImmunoPrecise Sets March 13 Earnings CallWhat's Next for This Biotech Innovator? - StockTitan

Mar 05, 2025
pulisher
Mar 05, 2025

IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 13, 2025 - Yahoo Finance

Mar 05, 2025
pulisher
Feb 27, 2025

ImmunoPrecise Antibodies Ltd. (IPA) Expands AI Leadership with Dr. Kamil Isaev Appointment - Insider Monkey

Feb 27, 2025
pulisher
Feb 27, 2025

IPA and Ribopro form mRNA antibody discovery collaboration - Yahoo Finance

Feb 27, 2025
pulisher
Feb 26, 2025

ImmunoPrecise Antibodies appoints Joseph Scheffler interim CFO - MSN

Feb 26, 2025
pulisher
Feb 26, 2025

IPA and RIBOPRO Partner to Advance mRNA-Driven Antibody Discovery, Unlocking New Frontiers in Immunotherapy - 01Net

Feb 26, 2025
pulisher
Feb 26, 2025

ImmunoPrecise & RIBOPRO Partner for AI-Powered Antibody Discovery - Contract Pharma

Feb 26, 2025
pulisher
Feb 26, 2025

ImmunoPrecise Antibodies and RIBOPRO Partner to Revolutionize Antibody Discovery - TipRanks

Feb 26, 2025
pulisher
Feb 24, 2025

ImmunoPrecise Antibodies annonce un remaniement de son équipe de direction - The Hastings Tribune

Feb 24, 2025
pulisher
Feb 24, 2025

ImmunoPrecise Antibodies Announces Key Leadership Changes - Voice Of Alexandria

Feb 24, 2025
pulisher
Feb 24, 2025

AI Pioneer Joins ImmunoPrecise Board: Can New Leadership Accelerate Biotech Innovation? - StockTitan

Feb 24, 2025
pulisher
Feb 20, 2025

ImmunoPrecise Antibodies Transfers to Nasdaq Capital Market, Gains Extension - TipRanks

Feb 20, 2025
pulisher
Feb 20, 2025

Immunoprecise Antibodies Announces Transfer To Nasdaq Capital Market And Extension Of Bid Price Compliance Period - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

ImmunoPrecise Antibodies Announces Transfer to Nasdaq Capital Market and Extension of Bid Price Compliance Period - Business Wire

Feb 20, 2025
pulisher
Feb 07, 2025

ImmunoPrecise Antibodies Ltd (IPA) Shares Up Despite Recent Market Volatility - The News Heater

Feb 07, 2025
pulisher
Feb 06, 2025

Check Out ImmunoPrecise Antibodies Ltd (IPA)’s Trade Data Rather Than the Analysts’ Views - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

ImmunoPrecise Antibodies Ltd (IPA) presents a great opportunity, but the stock is slightly overvalued - US Post News

Feb 05, 2025
pulisher
Feb 03, 2025

ImmunoPrecise Antibodies Boosts Financial Position Through Successful Capital Initiatives - TipRanks

Feb 03, 2025
pulisher
Jan 28, 2025

ImmunoPrecise Antibodies (OTCMKTS:IPATF) Shares Down 3.9% – Here’s Why - Defense World

Jan 28, 2025
pulisher
Jan 27, 2025

ImmunoPrecise Antibodies Ltd. (IPA) Unveils AI-Developed GLP-1 Therapies for Type 2 Diabetes and Obesity, Pioneering New Frontiers in Biotech Innovation - Insider Monkey

Jan 27, 2025
pulisher
Jan 27, 2025

ImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville Debenture - The Globe and Mail

Jan 27, 2025
pulisher
Jan 27, 2025

ImmunoPrecise Antibodies Strengthens Financial Position with Strategic Capital Initiatives - TipRanks

Jan 27, 2025
pulisher
Jan 26, 2025

ImmunoPrecise Antibodies (NASDAQ:IPA) Subsidiary BioStrand Introduces Breakthrough AI Model In Life Sciences, Harnessing LLM Stacking And HYFT Technology - ACCESS Newswire

Jan 26, 2025
pulisher
Jan 24, 2025

Benchmark maintains Buy on Immunoprecise stock, target at $3.00 - MSN

Jan 24, 2025
pulisher
Jan 24, 2025

Benchmark maintains Buy on Immunoprecise stock, target at $3.00 By Investing.com - Investing.com Canada

Jan 24, 2025
pulisher
Jan 23, 2025

Immunoprecise uses AI to develop new class of GLP-1 therapies - BioWorld Online

Jan 23, 2025
pulisher
Jan 23, 2025

ImmunoPrecise Antibodies develops new class of GLP-1 therapies through AI - Yahoo Finance

Jan 23, 2025
pulisher
Jan 23, 2025

Stock Traders Buy High Volume of ImmunoPrecise Antibodies Call Options (NASDAQ:IPA) - Defense World

Jan 23, 2025
pulisher
Jan 22, 2025

What's Going On With ImmunoPrecise Antibodies Stock Wednesday? - Benzinga

Jan 22, 2025
pulisher
Jan 22, 2025

S&P 500 Growth (IGX) QuotePress Release - The Globe and Mail

Jan 22, 2025
pulisher
Jan 22, 2025

TSX Renewable and Clean Tech Index (TXCT) QuotePress Release - The Globe and Mail

Jan 22, 2025
pulisher
Jan 22, 2025

TSX 60 Index (TXSX) QuotePress Release - The Globe and Mail

Jan 22, 2025

Immunoprecise Antibodies Ltd Stock (IPA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$78.94
price up icon 2.53%
$318.85
price up icon 1.51%
$33.41
price up icon 0.00%
$20.11
price up icon 1.41%
$99.27
price up icon 0.31%
biotechnology ONC
$266.26
price up icon 1.87%
Cap:     |  Volume (24h):